Vanrx Pharmasystems, a manufacturer of advanced aseptic filling systems for the pharmaceutical industry, has announced that Shreedhar Instruments has become its exclusive distributor in India.
"India's pharmaceutical sector will grow to its greatest potential by using flexible manufacturing technologies that enhance competitiveness. Indian companies are investing in biosimilars and complex injectables. Vanrx was created by biotech experts to design a new type of production system, called an Aseptic Filling Workcell. Companies using their systems move injectable drugs to market faster," said Shreedhar Joshi, Managing Partner of Shreedhar Instruments.
"Vanrx's systems are an excellent fit for drug companies who want to make complex, high-value sterile injectables. This system provides excellent compliance levels and reduces key areas of risk, thereby providing a perfect machine for exporting into the U.S., Europe and similar regulatory markets," he adds.
"Shreedhar Instruments came highly recommended, and they already do business with many of the leading Indian pharmaceutical companies. Their sales and service teams are well-trained, and will provide excellent service to our existing and future customers. India is an important market for Vanrx and we look forward to a strong relationship," said Greg Speakman, vice president, sales and marketing for Vanrx.
Based in Vadodara, and with offices in Ahmedabad, Mumbai, Hyderabad, and Pune, and sales and service teams in Bengaluru, Chandigarh, Goa, Surat and Vapi, Shreedhar Instruments covers all of India's major pharmaceutical manufacturing centers.
The SA25 Aseptic Filling Workcell uses robotics to perform all material handling, filling and container closing activities. It was designed by pharmaceutical veterans who wanted to solve long-standing aseptic processing problems within conventional fill-finish systems. Their goal was to make the production of complex injectable drug products easier and improve patient safety.
Key benefits of the SA25 Workcell include:
Lowers costs by using less space, fewer utilities and less operators than conventional systems.
Flexibility to fill and close vials, syringes or cartridges with industry-leading quality.
Efficient production of multiple products through fast changeover and batch cycling times.
Shortens time to construct filling operations or add capacity through a standardized design.
Scale production through additional Workcells to support flexible manufacturing capacity.
For more information, click here
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
